Z Y Huang1, E Perry2, J L Huebner3, B Katz4, Y-J Li5, V B Kraus6. 1. Department of Orthopedic Surgery, West China Hospital, West China Medical School, SiChuan University, ChengDu, SiChuan Province, People's Republic of China; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA. Electronic address: zey.huang@gmail.com. 2. Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA. Electronic address: emily.p.perry@duke.edu. 3. Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA. Electronic address: jhuebner@duke.edu. 4. Department of Biostatistics, Indiana University, Indianapolis, IN, USA. Electronic address: bkatz@iu.edu. 5. Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA. Electronic address: yiju.li@duke.edu. 6. Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA; Division of Rheumatology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA. Electronic address: vbk@duke.edu.
Abstract
OBJECTIVE: To evaluate systemic inflammatory biomarkers in symptomatic knee osteoarthritis (OA) and their association with radiographic and biochemical OA progression. METHODS: Lipopolysaccharide (LPS) binding protein (LBP), soluble Toll-like receptor 4 (sTLR4) and interleukin 6 (IL-6) were measured in plasma of 431 knee OA patients from the doxycycline (DOXY) trial at baseline and 18 months. Plasma lipopolysaccharide and lipopolysaccharide binding protein (LBP) were also measured at 12 months. As a biochemical indicator of disease activity and OA progression, urinary (u) C-telopeptide of Type II collagen (uCTX-II) was measured in samples collected at baseline and 18 months. Change over 16 months in radiographic tibiofemoral joint space width (JSW in mm) and joint space narrowing (JSN≥0.5 mm) were used to indicate radiographic OA progression. Change over 18 months for uCTX-II was used as a secondary outcome. Both univariate and multivariable regression analyses were performed to test the association between Z-score transformed biomarkers and outcomes. RESULTS: Baseline LBP and time-integrated concentration (TIC) of LBP over 12 and 18 months were associated with worsening joint space width (JSW) (parameter estimates: -0.1 to -0.07) and JSN (OR: 1.32 to 1.42) adjusting for treatment group, age, body mass index (BMI) and corresponding baseline radiographic measures. Baseline sTLR4 and TIC over 18 months were associated with change in uCTX-II over 18 months (adjusted parameter estimates: 0.0017 to 0.0020). Results were not modified by treatment with doxycycline. CONCLUSION: Plasma LBP and sTLR4 were associated with knee OA progression over 16-18 months. These results lend further support for a role of systemic low-grade inflammation in the pathogenesis of knee OA progression.
OBJECTIVE: To evaluate systemic inflammatory biomarkers in symptomatic knee osteoarthritis (OA) and their association with radiographic and biochemical OA progression. METHODS:Lipopolysaccharide (LPS) binding protein (LBP), soluble Toll-like receptor 4 (sTLR4) and interleukin 6 (IL-6) were measured in plasma of 431 knee OApatients from the doxycycline (DOXY) trial at baseline and 18 months. Plasma lipopolysaccharide and lipopolysaccharide binding protein (LBP) were also measured at 12 months. As a biochemical indicator of disease activity and OA progression, urinary (u) C-telopeptide of Type II collagen (uCTX-II) was measured in samples collected at baseline and 18 months. Change over 16 months in radiographic tibiofemoral joint space width (JSW in mm) and joint space narrowing (JSN≥0.5 mm) were used to indicate radiographic OA progression. Change over 18 months for uCTX-II was used as a secondary outcome. Both univariate and multivariable regression analyses were performed to test the association between Z-score transformed biomarkers and outcomes. RESULTS: Baseline LBP and time-integrated concentration (TIC) of LBP over 12 and 18 months were associated with worsening joint space width (JSW) (parameter estimates: -0.1 to -0.07) and JSN (OR: 1.32 to 1.42) adjusting for treatment group, age, body mass index (BMI) and corresponding baseline radiographic measures. Baseline sTLR4 and TIC over 18 months were associated with change in uCTX-II over 18 months (adjusted parameter estimates: 0.0017 to 0.0020). Results were not modified by treatment with doxycycline. CONCLUSION: Plasma LBP and sTLR4 were associated with knee OA progression over 16-18 months. These results lend further support for a role of systemic low-grade inflammation in the pathogenesis of knee OA progression.
Authors: Kenneth D Brandt; Steven A Mazzuca; Barry P Katz; Kathleen A Lane; Kenneth A Buckwalter; David E Yocum; Frederick Wolfe; Thomas J Schnitzer; Larry W Moreland; Susan Manzi; John D Bradley; Leena Sharma; Chester V Oddis; Steven T Hugenberg; Louis W Heck Journal: Arthritis Rheum Date: 2005-07
Authors: S Gilbertson-Beadling; E A Powers; M Stamp-Cole; P S Scott; T L Wallace; J Copeland; G Petzold; M Mitchell; S Ledbetter; R Poorman Journal: Cancer Chemother Pharmacol Date: 1995 Impact factor: 3.333
Authors: P S Tobias; J Mathison; D Mintz; J D Lee; V Kravchenko; K Kato; J Pugin; R J Ulevitch Journal: Am J Respir Cell Mol Biol Date: 1992-09 Impact factor: 6.914
Authors: José Luis Leante-Castellanos; Luis García de Guadiana-Romualdo; Carmen Fuentes-Gutiérrez; Ana Hernando-Holgado; Ana García-González; Enrique Jiménez-Santos Journal: J Perinat Med Date: 2015-03 Impact factor: 1.901
Authors: Tarvo Sillat; Gonçalo Barreto; Paul Clarijs; Antti Soininen; Mari Ainola; Jukka Pajarinen; Matti Korhonen; Yrjö T Konttinen; Regina Sakalyte; Mika Hukkanen; Pekka Ylinen; Dan C E Nordström Journal: Acta Orthop Date: 2013-11-18 Impact factor: 3.717
Authors: Richard F Loeser; Liubov Arbeeva; Kathryn Kelley; Anthony A Fodor; Shan Sun; Veronica Ulici; Lara Longobardi; Yang Cui; Delisha A Stewart; Susan J Sumner; M Andrea Azcarate-Peril; R Balfour Sartor; Ian M Carroll; Jordan B Renner; Joanne M Jordan; Amanda E Nelson Journal: Arthritis Rheumatol Date: 2022-01-04 Impact factor: 10.995
Authors: Sureka Naidu Rajandran; Cheryl Ann Ma; Jin Rong Tan; Jin Liu; Steven Bak Siew Wong; Ying-Ying Leung Journal: Front Med (Lausanne) Date: 2020-11-12
Authors: Cale A Jacobs; Ryan A Mace; Jonathan Greenberg; Paula J Popok; Mira Reichman; Christian Lattermann; Jessica L Burris; Eric A Macklin; Ana-Maria Vranceanu Journal: Contemp Clin Trials Commun Date: 2021-01-28